secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2026-08-04T20:33:21+00:00
Accession:  0001627223-26-000021
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours Q2 2026: Net loss $274M, Adj. EPS $0.42, revenue flat at $1.6B
-----------------------------------------------------------------------

- Net loss $274M ($1.81/sh) vs $380M loss ($2.53/sh) prior year; adjusted net income $64M ($0.42/sh) vs $91M ($0.61/sh).
- Net sales $1.6B flat YoY; Adjusted EBITDA $247M vs $260M prior year.
- Free cash flow improved 128% YoY; net leverage declined to 4.4x; free cash flow conversion 46%.
- Announced global TiO2 price increase effective June 1, 2026; APM Performance Solutions sales up 8% YoY.
- CEO Denise Dignam cites disciplined execution and progress on balance sheet and legacy litigation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000162722326000021/0001627223-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000162722326000021/cc-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001627223-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer